Search Results - Denice Tsao‐Wei

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Early Ductal Decompression Versus Conservative Management for Gallstone Pancreatitis With Ampullary Obstruction

    Early Ductal Decompression Versus Conservative Management for Gallstone Pancreatitis With Ampullary Obstruction by Juan M. Acosta, Namir Katkhouda, Khaldoun A. Debian, Susan Groshen, Denice Tsao‐Wei, Thomas V. Berne

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells

    Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells by Cuong Nguyen, Gangning Liang, Tuyen Thi Thanh Nguyen, Denice Tsao‐Wei, Susan Groshen, Michael Lübbert, Jiajun Zhou, William F. Benedict, Peter A. Jones

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice

    Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academi... by Michael F. Press, Ivonne Villalobos, Angela Santiago, Roberta Guzman, Monica Cervantes, Armen Yuri Gasparyan, Anaamika Campeau, Yanling Ma, Denice Tsao‐Wei, Susan Groshen

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    <i>RUNX3</i> Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking

    <i>RUNX3</i> Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking by Erika M. Wolff, Gangning Liang, Connie C. Cortez, Yvonne Tsai, Jose E. Castelao, Victoria K. Cortessis, Denice Tsao‐Wei, Susan Groshen, Peter A. Jones

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Safety and feasibility of fasting in combination with platinum-based chemotherapy

    Safety and feasibility of fasting in combination with platinum-based chemotherapy by Tanya B. Dorff, Susan Groshen, Agustin A. García, Manali Shah, Denice Tsao‐Wei, Huyen Q. Pham, Chia‐Wei Cheng, Sebastian Brandhorst, Pinchas Cohen, Min Wei, Valter D. Longo, David I. Quinn

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma

    A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma by Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao‐Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen, Mark Kirschbaum, Mark A. Schroeder, Edward M. Newman

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial by Steven G. DuBois, Louis Chesler, Susan Groshen, Randall A. Hawkins, Fariba Goodarzian, Hiroyuki Shimada, Greg Yanik, Michael Tagen, Clinton Stewart, Yaël P. Mossé, John M. Maris, Denice Tsao‐Wei, Araz Marachelian, Judith G. Villablanca, Katherine K. Matthay

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

    A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma by Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho, Min H. Kang, Susan L. Cohn, Clarke P. Anderson, Araz Marachelian, Susan Groshen, Denice Tsao‐Wei, Katherine K. Matthay, John M. Maris, Charlotte E. Hasenauer, Scarlett Czarnecki, Hollie Lai, Fariba Goodarzian, Hiro Shimada, C. Patrick Reynolds

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial by Michael D. Hogarty, David S. Ziegler, Andrea Franson, Yueh‐Yun Chi, Denice Tsao‐Wei, Kangning Liu, Rohan Vemu, Eugene W. Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M. Balis, Susan Groshen, Murray D. Norris, Michelle Haber, Julie R. Park, Katherine K. Matthay, Araz Marachelian

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    <i>HER2</i> Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

    <i>HER2</i> Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enr... by Michael F. Press, Guido Sauter, Marc Buyse, Hélène Fourmanoir, Emmanuel Quinaux, Denice Tsao‐Wei, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, John Crown, Miguel Martín, Vicente Valero, John R. Mackey, Valerie Bée, Yanling Ma, Ivonne Villalobos, Anaamika Campeau, Martina Mirlacher, Mary-Ann Lindsay, Dennis J. Slamon

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

    Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approac... by Steven G. DuBois, Araz Marachelian, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Susan Groshen, Jemily Malvar, Rochelle Bagatell, Lars M. Wagner, John M. Maris, Randall A. Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao‐Wei, Katherine K. Matthay, Yaël P. Mossé

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

    131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phas... by Gregory A. Yanik, Judith G. Villablanca, John M. Maris, Brian Weiss, Susan Groshen, Araz Marachelian, Julie R. Park, Denice Tsao‐Wei, Randall A. Hawkins, Barry L. Shulkin, Hollie Jackson, Fariba Goodarzian, Hiro Shimada, Jesse Courtier, Raymond J. Hutchinson, Daphne Haas-Koga, C. Beth Hasenauer, Scarlett Czarnecki, Howard M. Katzenstein, Katherine K. Matthay

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial

    Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial by Katherine K. Matthay, Brian Weiss, Judith G. Villablanca, John M. Maris, Gregory A. Yanik, Steven G. DuBois, James B. Stubbs, Susan Groshen, Denice Tsao‐Wei, Randall A. Hawkins, Hollie Jackson, Fariba Goodarzian, Heike E. Daldrup‐Link, Ashok Panigrahy, Alexander J. Towbin, Hiroyuki Shimada, John Barrett, Norman LaFrance, John W. Babich

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

    Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma by Steven G. DuBois, Susan Groshen, Julie R. Park, Daphne A. Haas‐Kogan, Xiao-Dong Yang, Ethan G. Geier, Eugene Chen, Kathy Giacomini, Brian Weiss, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Randall A. Hawkins, Jesse Courtier, Hollie Jackson, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao‐Wei, Judith G. Villablanca, Araz Marachelian, Katherine K. Matthay

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Con... by Steven G. DuBois, Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G. Villablanca, Kieuhoa T. Vo, Navin Pinto, Yaël P. Mossé, John M. Maris, Suzanne Shusterman, Susan L. Cohn, Kelly C. Goldsmith, Brian Weiss, Gregory A. Yanik, Clare J. Twist, Meredith S. Irwin, Daphne A. Haas‐Kogan, Julie R. Park, Araz Marachelian, Katherine K. Matthay

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma by Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Renee M. McGovern, Susan Groshen, Rochelle Bagatell, John M. Maris, Clare J. Twist, Kelly C. Goldsmith, Meaghan Granger, Brian Weiss, Julie R. Park, Margaret E. Macy, Susan L. Cohn, Greg Yanik, Lars M. Wagner, Randall A. Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Chunqiao Luo, Denice Tsao‐Wei, Katherine K. Matthay, Araz Marachelian

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: